106.73USD-0.83%Mkt Cap: 12.21B $P/E: 31.56Today
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's …
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap12.21B $
Enterprise Value13.99B $
Revenue (TTM)1.66B $
Gross Profit1.17B $
Net Income (TTM)316.89M $
Revenue/Share14.15 USD
Last Price106.73 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees423
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS40637H1095
Valuation
P/E (Trailing)31.56
P/E (Forward)10.21
PEG—
EV/EBITDA13.32
EV/Revenue8.41
P/S7.24
P/B84.29
EPS (TTM)3.36
EPS (Forward)10.39
52W Range
61.2397% of range107.96
52W High107.96 USD
52W Low61.23 USD
Profitability
Gross Margin83.62%
Oper. Margin59.80%
EBITDA Margin63.15%
Profit Margin22.69%
ROE649.18%
ROA12.55%
Growth
Revenue Growth47.70%
Earnings Growth42.90%
Cash Flow & Leverage
Operating CF651.56M $
CapEx (TTM)294.74M $
FCF Margin20.27%
FCF Yield2.76%
Net Debt1.95B $
Net Debt/EBITDA1.85
Balance Sheet
Debt/Equity43.89
Current Ratio2.71
Quick Ratio1.99
Book Value/Sh1.259 USD
Cash/Share2.035 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)99.56 USD
Upside (mean)-6.7%
Target Range70.00 USD – 115.00 USD
$70.00-6.7% to mean$115.00
# Analysts9
Ownership
Shares Out.113.50M
Float112.17M
Insiders1.11%
Institutions112.35%
Short Interest
Short Ratio7.9d
Short % Float16.19%
Short % Out.12.35%
Shares Short14.02M
Short (prev mo.)13.23M
Technical
SMA 5082.28 (+29.7%)
SMA 20072.06 (+48.1%)
Beta0.85
S&P 52W Chg18.16%
Avg Vol (30d)2.07M
Avg Vol (10d)3.10M
Technical Indicators
RSI (14)80.8
MACD7.1601
MACD Signal5.7522
MACD Hist.+1.4079
BB Upper111.08 USD
BB Middle90.48 USD
BB Lower69.87 USD
BB Width45.55%
ATR (14)3.474 USD
Vol Ratio (20d)1.12x